Clinical Trials
145
Active:121
Completed:10
Trial Phases
3 Phases
Phase 1:114
Phase 2:4
Phase 3:11
Drug Approvals
2
NMPA:2
Drug Approvals
Efgartigimod Alfa Injection (Subcutaneous Injection)
- Product Name
- 卫力迦
- Approval Number
- 国药准字SJ20240029
- Approval Date
- Jul 9, 2024
NMPA
Efgartigimod Alfa Injection
- Product Name
- 卫伟迦
- Approval Number
- 国药准字SJ20230008
- Approval Date
- Jun 30, 2023
NMPA
Clinical Trials
Distribution across different clinical trial phases (129 trials with phase data)• Click on a phase to view related trials
Phase 1
114 (88.4%)Phase 3
11 (8.5%)Phase 2
4 (3.1%)No trials found
News
No news found